Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cipher Pharmaceuticals Inc
T.CPH
Alternate Symbol(s):
CPHRF
Healthcare
Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the...
United States and South America. Its Dermatology products include Actikerall, Epuris, Ozanex and Vaniqa. Its Hospital Acute Care products include Aggrastat and Brinavess. Its Out-Licensed products include Absorica, ConZip and Lipofen. The Company is also focused on building a portfolio of prescription medicines that serve unmet medical needs. The Company's product pipeline development programs including MOB-015, DTR-001, and CF-101. The Company's subsidiaries include Cipher US Holdings Inc., Cipher US Holdco LLC, and Cipher Pharmaceuticals US LLC.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(28)
•••
stockfy
X
View Profile
View Bullboard History
Comment by
stockfy
on Feb 17, 2021 1:27pm
RE:Dirt-cheap CPH: Many growth initiatives in 2021-2022
After the recent deal for the hospital products with Verity, a deal with Galephar could be next.
(28)
•••
stockfy
X
View Profile
View Bullboard History
Comment by
stockfy
on Feb 17, 2021 11:25am
RE:Dirt-cheap CPH: Additional growth opportunities in 2021-2022
CPH just did what it promised a few days ago. The deal with Verity for the hospital products.
C.RVV Announces Type C Meeting Request Granted by FDA for Clinical Study
posted Apr 24, 2024 9:00am by
Revive Therapeutics Ltd.
-
|
Currently, the Company is exploring the use of Bucillamine as a potential treatment for long COVID. The Company is advancing the clinical development of Bucillamine by leveraging the published research and data from its previous Phase 3 clinical trial (the “Study”) and is finalizing the regulatory and clinical package that includes a proposed clinical study for long COVID to present to the FDA ...read more
(28)
•••
stockfy
X
View Profile
View Bullboard History
Post by
stockfy
on Feb 11, 2021 4:31am
CPH Buys Back Another 205,000 shares in Q4 2020 !
Profitable and debt-free CPH knows that it's dirt cheap because it currently trades less than 2 times its 2020 EBITDA. As such, it just announced that it bought back 205,000 shares in Q4 2020
...more
(28)
•••
stockfy
X
View Profile
View Bullboard History
Post by
stockfy
on Feb 11, 2021 4:23am
CPH's Hospital Products: Deal with Verity -> Revenue Growth
Good news. CPH just announced a deal for its hospital products that will contribute to revenue growth in the next months: https://cipher.investorroom.com/2021-02-10-Cipher-Pharmaceuticals-Enters-into
...more
(114)
•••
Majictrader
X
View Profile
View Bullboard History
Comment by
Majictrader
on Feb 10, 2021 11:57pm
RE:RE:Dirt-cheap CPH: Its Tattoo Removal Cream (Reuters UPDATE)
Finally they have partnered wirh Verity n no reaction here :). Looks like all sold and moved on...lol.
(7)
•••
maxxie3
X
View Profile
View Bullboard History
Comment by
maxxie3
on Jan 31, 2021 8:38am
RE:Dirt-cheap CPH: Its Tattoo Removal Cream (Reuters UPDATE)
Tattoo removal cream really ? do you think that's a catalyst to move the stock its pre-clinical? what 10-15 years from now have they even done testing on humans... Why are you doing the PR. They
...more
(28)
•••
stockfy
X
View Profile
View Bullboard History
Post by
stockfy
on Jan 29, 2021 3:16am
Dirt-cheap CPH: Its Tattoo Removal Cream (Reuters UPDATE)
CPH's tattoo removal cream could be a hit with so many people having changed their minds regarding their tattoos. See the latest news from CPH: https://medium.com/@jack_nuclear/a-tattoo-removal
...more
(28)
•••
stockfy
X
View Profile
View Bullboard History
Post by
stockfy
on Jan 24, 2021 5:34am
Dirt-cheap CPH: Additional growth opportunities in 2021-2022
In my previous post, I posted facts about the existing core products that generate revenue (Epuris, Absorica, Absorica LD) and the core drugs in the pipeline (tattoo, Galephar and alitretinoin, Moberg
...more
(28)
•••
stockfy
X
View Profile
View Bullboard History
Post by
stockfy
on Jan 24, 2021 5:17am
Dirt-cheap CPH: Many growth initiatives in 2021-2022
It's not only the ongoing cost reduction plan whose results will become more obvious in 2021, so debt-free and profitable CPH will expand further its high profit margins. CPH has additional
...more
(28)
•••
stockfy
X
View Profile
View Bullboard History
Post by
stockfy
on Jan 24, 2021 4:55am
CPH repurchased at C$1.14 and Employees bought at C$1.05
In August 2020, debt-free and profitable CPH announced that the TSX had approved the company’s Notice of Intention to make a Normal Course Issuer Bid. So during the period ended September 30, 2020
...more
(28)
•••
stockfy
X
View Profile
View Bullboard History
Post by
stockfy
on Jan 24, 2021 3:43am
Dirt-cheap CPH: EV-to-Rev is 0.8x, EV-to-EBITDA is 1.3x!
All figures below are in USD. CPH paid off its $1.7 million debt at October 30, 2020, according to its latest press release, facts below: "As of September 30, 2020, the Company had
...more
(28)
•••
stockfy
X
View Profile
View Bullboard History
Post by
stockfy
on Jan 24, 2021 3:31am
Debt-free CPH: Insiders own 41% (see MIC on Sedar)
Insiders own almost 41% in debt-free CPH, see the most recent Management Information Circular filed on Sedar, so their interests are aligned with shareholders'.
(20)
•••
Cgbuddy
X
View Profile
View Bullboard History
Post by
Cgbuddy
on Jan 22, 2021 12:19pm
hi my next entry point is 0.83
gl all
(800)
•••
SouthernTierTom
X
View Profile
View Bullboard History
Post by
SouthernTierTom
on Jan 21, 2021 12:08pm
Buying here in the US is driving today's move
Some might argue it's doing the opposite of what is being strongly "advertisied" Hey Ciao... Thanks for the "reach out" ...too bad you blew out SQD when you...new 52 week
...more
(20)
•••
Cgbuddy
X
View Profile
View Bullboard History
Comment by
Cgbuddy
on Jan 21, 2021 11:09am
RE:CPH: Debt-Free since October 30, 2020
ca you explain the big dump to 0.70 cent ? i hesitate to enter this stock as new investor ,it seem a lot of occult selling have occur 5 day ago in a market rally seem strange....
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Stage Set for Creation of a Leading Intermediate Gold Producer
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth